Illumina/ILMN
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX
About Illumina
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Ticker
ILMN
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
San Diego, United States
Employees
10,615
Website
www.illumina.com
Illumina Metrics
BasicAdvanced
$17B
Market cap
-
P/E ratio
-$8.15
EPS
1.19
Beta
-
Dividend rate
Price and volume
Market cap
$17B
Beta
1.19
Financial strength
Current ratio
1.752
Quick ratio
1.193
Long term debt to equity
38.193
Total debt to equity
39.693
Interest coverage (TTM)
-1.17%
Management effectiveness
Return on assets (TTM)
-0.62%
Return on equity (TTM)
-20.76%
Valuation
Price to revenue (TTM)
3.72
Price to book
2.93
Price to tangible book (TTM)
67.48
Price to free cash flow (TTM)
45.62
Growth
Revenue change (TTM)
1.01%
Earnings per share change (TTM)
-71.43%
3-year revenue growth
8.96%
3-year earnings per share growth
23.95%
What the Analysts think about Illumina
Analyst Ratings
Majority rating from 24 analysts.
Illumina Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$1.1B
-4.10%
Net income
-$126M
-28.00%
Profit margin
-11.71%
-24.89%
Illumina Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.32
$0.33
$0.14
$0.09
-
Expected
$0.02
$0.12
$0.02
$0.04
$0.08
Surprise
1,636.39%
167.61%
685.94%
106.42%
-
Illumina News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Illumina stock?
Illumina (ILMN) has a market cap of $17B as of July 03, 2024.
What is the P/E ratio for Illumina stock?
The price to earnings (P/E) ratio for Illumina (ILMN) stock is 0 as of July 03, 2024.
Does Illumina stock pay dividends?
No, Illumina (ILMN) stock does not pay dividends to its shareholders as of July 03, 2024.
When is the next Illumina dividend payment date?
Illumina (ILMN) stock does not pay dividends to its shareholders.
What is the beta indicator for Illumina?
Illumina (ILMN) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Illumina stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.